Feizhou Jiang

625 total citations
18 papers, 508 citations indexed

About

Feizhou Jiang is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Feizhou Jiang has authored 18 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Obstetrics and Gynecology. Recurrent topics in Feizhou Jiang's work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Feizhou Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Feizhou Jiang collaborates with scholars based in China, Italy and Slovenia. Feizhou Jiang's co-authors include Fangyuan Wang, Xiaoping Wan, Huan Tong, Xiaoping Wan, Qi Che, Yinyan He, Hui Wang, Yan Qin, Te Liu and Xiaoyue Chen and has published in prestigious journals such as ACS Nano, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Feizhou Jiang

17 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feizhou Jiang China	10	328	218	106	99	52	18	508
Hsin‐Yi Lan Taiwan	5	236 0.7×	167 0.8×	219 2.1×	90 0.9×	41 0.8×	6	463
Yuquan Zhang China	14	231 0.7×	123 0.6×	51 0.5×	86 0.9×	66 1.3×	30	429
Xinyuan Yang China	11	251 0.8×	146 0.7×	59 0.6×	72 0.7×	44 0.8×	28	480
Andrzej Bieńkiewicz Poland	11	323 1.0×	193 0.9×	102 1.0×	79 0.8×	68 1.3×	58	570
Ayako Kim Japan	6	271 0.8×	119 0.5×	116 1.1×	57 0.6×	32 0.6×	6	443
Jingxin Ding China	16	686 2.1×	597 2.7×	81 0.8×	65 0.7×	60 1.2×	41	925
Stephanie Gomez United States	7	336 1.0×	127 0.6×	129 1.2×	128 1.3×	9 0.2×	10	517
Yongtao Gao China	7	297 0.9×	259 1.2×	83 0.8×	40 0.4×	17 0.3×	7	429
Liangsheng Fan China	17	325 1.0×	163 0.7×	232 2.2×	133 1.3×	27 0.5×	29	591

Countries citing papers authored by Feizhou Jiang

Since Specialization

Citations

This map shows the geographic impact of Feizhou Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feizhou Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feizhou Jiang more than expected).

Fields of papers citing papers by Feizhou Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feizhou Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feizhou Jiang. The network helps show where Feizhou Jiang may publish in the future.

Co-authorship network of co-authors of Feizhou Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Feizhou Jiang. A scholar is included among the top collaborators of Feizhou Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feizhou Jiang. Feizhou Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Li, Pu, Li Chen, Kun Yu, et al.. (2025). Isorhynchophylline Inhibits NLRP3 Inflammasome and Improves Gestational Diabetes. Archivum Immunologiae et Therapiae Experimentalis. 73(1). 1 indexed citations

Chen, Li, et al.. (2024). Experiences and needs of Chinese women after a stillbirth: a qualitative phenomenological study. BMJ Open. 14(9). e088079–e088079. 1 indexed citations

Yan, Weiwei, Qi Wang, Jing Huang, et al.. (2024). A postoperative tumor-specific death prediction model for patients with endometrial cancer: a retrospective study. Translational Cancer Research. 13(2). 1083–1090.

Wang, Yingyao, Lin Zhang, Qin Liu, et al.. (2023). Cancer Cell Membrane-Enveloped Dexamethasone Normalizes the Tumor Microenvironment and Enhances Gynecologic Cancer Chemotherapy. ACS Nano. 17(17). 16703–16714. 33 indexed citations

Chen, Xiaoyue, et al.. (2022). Long Non-Coding RNA ZEB2-AS1 Augments Activity of Trophoblast Cells and Prevents the Development of Recurrent Spontaneous Abortion in Mice Through EZH2-Mediated CST3 Inhibition. Reproductive Sciences. 29(3). 963–974. 8 indexed citations

Zhang, Jing, Dandan Zhang, Xiaofang Yan, & Feizhou Jiang. (2021). The expression level and prognostic value of microRNA-15a-5p in endometrial carcinoma. Translational Cancer Research. 10(11). 4838–4844. 5 indexed citations

Yan, Xiaofang, Huilin Zhang, Yongli Zhang, et al.. (2020). Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9. Translational Cancer Research. 9(4). 2220–2230. 8 indexed citations

Sun, Ya Nan, Jun Shao, Feizhou Jiang, et al.. (2018). CD33⁺CD14⁺CD11b⁺HLA‐DR⁻ monocytic myeloid‐derived suppressor cells recruited and activated by CCR9/CCL25 are crucial for the pathogenic progression of endometriosis. American Journal of Reproductive Immunology. 81(1). e13067–e13067. 26 indexed citations

Wang, Xiaojun, Feizhou Jiang, Huan Tong, et al.. (2017). Dicer1 dysfunction promotes stemness and aggression in endometrial carcinoma. Tumor Biology. 39(4). 3726131196–3726131196. 8 indexed citations

10.

Zhang, Huilin, Xiaofang Yan, Yongli Zhang, et al.. (2017). ROR1 promotes the proliferation of endometrial cancer cells.. PubMed. 10(10). 10603–10610. 3 indexed citations

11.

Liu, Yuan, Tracy Murray Stewart, Robert A. Casero, et al.. (2017). Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth. International Journal of Oncology. 50(6). 2011–2023. 57 indexed citations

12.

Yang, Yixia, Qi Che, Feizhou Jiang, et al.. (2016). Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer. Tumor Biology. 37(9). 12203–12211. 46 indexed citations

13.

Tong, Huan, Feizhou Jiang, Xiaojun Wang, et al.. (2016). Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer. Cancer Letters. 376(1). 127–136. 60 indexed citations

14.

Wang, Huihui, Wei Bao, Feizhou Jiang, et al.. (2015). Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Letters. 360(2). 269–279. 44 indexed citations

15.

Chen, Zheng, Qi Che, Feizhou Jiang, et al.. (2015). Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer. Biochemical and Biophysical Research Communications. 463(4). 876–880. 42 indexed citations

16.

Li, Yiran, Qi Che, Yiding Bian, et al.. (2015). Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway. International Journal of Oncology. 47(3). 1017–1024. 20 indexed citations

17.

Jiang, Feizhou, Yinyan He, Huihui Wang, et al.. (2015). Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing. Oncotarget. 6(42). 44660–44674. 44 indexed citations

18.

Jiang, Feizhou, Te Liu, Yinyan He, et al.. (2011). MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer. 11(1). 425–425. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact